SEKISUI MEDICAL

SEKISUI MEDICAL CO., LTD. is composed of four major divisions: the Diagnostic Reagents Division, the Diagnostics Division, the Medical Equipment Division, the Pharmaceuticals Division, and the Pharmacokinetics Division. As the core division of the company, the Diagnostic Reagents Division focuses on the development capabilities in the lipid field to manufacture and sell clinical diagnostic reagents used in key disease areas such as lifestyle-related diseases and infectious diseases. The division's development and research of lipid testing reagent kits are world-leading. Our HDL-C and LDL-C testing kits were the first in the world to obtain certification from the U.S. CDC and hold a leading share of the global market. SEKISUI MEDICAL's new products in the blood coagulation and fibrinolysis fields, such as the Fibrin/Fibrinogen Degradation Products (FDP) diagnostic reagent kits, also occupy the majority share of the global market. Additionally, SEKISUI MEDICAL has introduced innovative new products in thrombosis diagnosis, therapeutic drug monitoring (TDM), and infectious diseases like syphilis, which differ from existing methods.